+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
FREDUN FREDUN

Fredun Pharmaceuticals Share Price

₹1,707.70 +73.45 (4.49%)
New 52W High today

19 Nov, 2026 4:01 PM (IST)

Fredun Pharmaceuticals live price: ₹1,707.70. It opened at ₹1,645 vs previous close ₹1,634; intraday high/low: ₹1,712/₹1,625. The 50 & 200 DMA stand at ₹1,439.60/₹1,078.20.

Fredun Pharmaceuticals Performance

  • Today's Low
  • ₹1,625
  • Today's High
  • ₹1,712
  • 52 Week Low
  • ₹454
  • 52 Week High
  • ₹1,712
  • Open Price₹1,645
  • Previous Close₹1,634
  • Volume170,799
  • 50 DMA₹1,439.60
  • 100 DMA₹1,301.90
  • 200 DMA₹1,078.20

Fredun Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 15.62%
  • Over 3 Month + 18.35%
  • Over 6 Month + 122.5%
  • Over 1 Year + 164.75%

Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!

Invest Now

Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 46.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 2,447
  • P/B Ratio
  • 8.8
  • Average True Range
  • 75.4
  • EPS
  • 37
  • Dividend Yield
  • 0
  • MACD Signal
  • 50
  • RSI
  • 69.74
  • MFI
  • 79.44

Latest Stock News Updates

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of the Earnings conference call held on 16th November, 2026 for Q2 H1 FY 2027.

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited.

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Dated 14.11.2026

Outcome of the Board Meeting of 'Fredun Pharmaceuticals Limited' ('Company') pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Fredun Pharmaceuticals Financials

Fredun Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,707.70
+ 73.45 (4.49%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,515.90
  • 50 Day
  • ₹1,439.60
  • 100 Day
  • ₹1,301.90
  • 200 Day
  • ₹1,078.20

Resistance and Support

1681.57 Pivot Speed
  • R3 1,825.10
  • R2 1,768.60
  • R1 1,738.10
  • S1 1,651.10
  • S2 1,594.60
  • S3 1,564.10

Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-05 Quarterly Results
2026-08-05 Quarterly Results
2026-05-25 Audited Results, Dividend & Bonus issue
2026-02-09 Quarterly Results
2025-11-08 Quarterly Results
Date Purpose Remarks
2026-06-23 FINAL Rs.0.70 per share(7%)Final Dividend
2025-09-23 FINAL Rs.0.70 per share(7%)Dividend
2024-09-23 FINAL Rs.0.70 per share(7%)Final Dividend
2023-09-22 FINAL Rs.0.70 per share(7%)Final Dividend
2022-09-15 FINAL Rs.0.70 per share(7%)Final Dividend
View Fredun Pharmaceuticals Dividend History Arrow
Date Purpose Remarks
2026-07-16 Bonus Bonus issue of equity shares in the ratio of 2:1 of Rs. 10/-.

Fredun Pharmaceuticals Shareholding Pattern

52.25%
43.62%
3.43%
0.69%

About Fredun Pharmaceuticals

Fredun Pharmaceuticals is dedicated to improving lives of people. Company’s aim is not only profitability but is effective efficiency. With years of experience in manufacturing various pharmaceutical formulations Fredun Pharmaceuticals Ltd has built a good reputation as a reliable and ethical Company having buyers which not only include leading Pharma Companies of India but also across Africa, South East Asia and CIS countries and Latin America. View More
  • NSE Symbol
  • FREDUN
  • BSE Symbol
  • 539730
  • Executive Director,Managing Director,Chief Financial Officer
  • Fredun N Medhora
  • ISIN
  • INE194R01017

Similar Stocks to Fredun Pharmaceuticals

Fredun Pharmaceuticals FAQs

Fredun Pharmaceuticals share price is ₹1,707 As on 19 November, 2026 | 19:56

The Market Cap of Fredun Pharmaceuticals is ₹2447 Cr As on 19 November, 2026 | 19:56

The P/E ratio of Fredun Pharmaceuticals is 46.2 As on 19 November, 2026 | 19:56

The PB ratio of Fredun Pharmaceuticals is 8.8 As on 19 November, 2026 | 19:56

The 52 week High & Low of Fredun Pharmaceuticals is ₹1712/₹454 respectively As on 19 November, 2026 | 19:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23